Related Experiment Video
Updated: Jul 13, 2026

10:44
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
In vitro study of the hypercoagulable state in multiple myeloma patients treated or not with thalidomide
Anna D Petropoulou1, Grigoris T Gerotziafas, Meyer M Samama
1Service d'Hématologie Biologique, Hôpital Hôtel-Dieu, Assistance Publique Hôpitaux de Paris, France. annakyla@hotmail.com
Thrombosis Research
|July 10, 2007
Abstract
No abstract available in PubMed .
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
